<h1>Paper Summary</h1>

<!--META_START-->

<p>Title: Reconciling evidence-based medicine and precision medicine in the era of big data: challenges and opportunities  </p>

<p>Authors: Jacques S. Beckmann, Daniel Lew  </p>

<p>DOI: 10.1186/s13073-016-0388-7  </p>

<p>Year: 2016  </p>

<p>Publication Type: Journal Article  </p>

<p>Discipline/Domain: Medicine / Clinical Bioinformatics  </p>

<p>Subdomain/Topic: Precision Medicine, Evidence-Based Medicine, Big Data Integration  </p>

<p>Eligibility: Eligible  </p>

<p>Overall Relevance Score: 85  </p>

<p>Operationalization Score: 70  </p>

<p>Contains Definition of Actionability: Yes (implicit, in terms of “clinically actionable knowledge”)  </p>

<p>Contains Systematic Features/Dimensions: Yes  </p>

<p>Contains Explainability: Yes  </p>

<p>Contains Interpretability: Partial  </p>

<p>Contains Framework/Model: Partial (conceptual integration model)  </p>

<p>Operationalization Present: Yes (data integration, bioinformatics workflow)  </p>

<p>Primary Methodology: Conceptual / Review  </p>

<p>Study Context: Integration of precision medicine and evidence-based medicine in big data healthcare  </p>

<p>Geographic/Institutional Context: Switzerland (SIB Swiss Institute of Bioinformatics), global implications  </p>

<p>Target Users/Stakeholders: Clinicians, bioinformaticians, healthcare policymakers, patients/citizens  </p>

<p>Primary Contribution Type: Conceptual framework and challenges/opportunities analysis  </p>

<p>CL: Yes  </p>

<p>CR: Yes  </p>

<p>FE: Yes  </p>

<p>TI: Partial  </p>

<p>EX: Yes  </p>

<p>GA: Yes  </p>

<p>Reason if Not Eligible: N/A  </p>

<!--META_END-->

<p><strong>Title:</strong> Reconciling evidence-based medicine and precision medicine in the era of big data: challenges and opportunities  </p>

<p><strong>Authors:</strong> Jacques S. Beckmann, Daniel Lew  </p>

<p><strong>DOI:</strong> 10.1186/s13073-016-0388-7  </p>

<p><strong>Year:</strong> 2016  </p>

<p><strong>Publication Type:</strong> Journal Article  </p>

<p><strong>Discipline/Domain:</strong> Medicine / Clinical Bioinformatics  </p>

<p><strong>Subdomain/Topic:</strong> Precision Medicine, Evidence-Based Medicine, Big Data Integration  </p>

<p><strong>Contextual Background:</strong> The paper addresses the tension and complementarity between precision medicine (individualized, data-driven care) and evidence-based medicine (population-derived guidelines), proposing a conceptual bridge enabled by big data, clinical bioinformatics, and global data-sharing.  </p>

<p><strong>Geographic/Institutional Context:</strong> Switzerland; global healthcare systems  </p>

<p><strong>Target Users/Stakeholders:</strong> Clinicians, bioinformaticians, policymakers, healthcare IT developers, patients/citizens  </p>

<p><strong>Primary Methodology:</strong> Conceptual / Review  </p>

<p><strong>Primary Contribution Type:</strong> Conceptual framework and challenge–opportunity mapping for integration of precision and evidence-based medicine.</p>

<h2>General Summary of the Paper</h2>

<p>This paper outlines how high-resolution, high-throughput biomedical technologies and big data can drive precision medicine, while highlighting its limitations compared to traditional evidence-based medicine. The authors propose “evidence-based precision medicine,” integrating the statistical robustness of population studies with the individualized tailoring of care enabled by molecular, environmental, and lifestyle data. They stress the role of clinical bioinformatics in converting heterogeneous datasets into clinically actionable knowledge. Key enablers include standardized data formats, interoperability, global data sharing, and patient empowerment. The authors foresee a shift from treatment to prevention, with citizens as active healthcare participants, but also note technical, semantic, ethical, and economic challenges.</p>

<h2>Eligibility</h2>

<p>Eligible for inclusion: <strong>Yes</strong></p>

<h2>How Actionability is Understood</h2>

<p>The authors frame actionability as the <strong>translation of big, heterogeneous biomedical datasets into “clinically actionable knowledge”</strong> for individual care and population-level benefit, enabled by clinical bioinformatics.</p>

<blockquote>
  <p>“Proper data mining and translation of the vast datasets into clinically actionable knowledge will require the application of clinical bioinformatics.” (p. 1)  </p>
</blockquote>

<blockquote>
  <p>“The real challenge… will be to curate, store, federate, integrate, share, mine, interpret, and transform these extensive heterogeneous data into scalable, medically actionable resources…” (p. 8)</p>
</blockquote>

<h2>What Makes Something Actionable</h2>

<ul>
<li><p>Standardization and interoperability of clinical and laboratory datasets  </p></li>
<li><p>Integration of multi-layered data (genomics, microbiome, lifestyle, environmental)  </p></li>
<li><p>Statistical robustness from large cohorts combined with individual-level granularity  </p></li>
<li><p>Ethical, legal, and privacy safeguards for trust in data sharing  </p></li>
<li><p>Explainable outputs that can guide clinical decisions at the point of care</p></li>
</ul>

<h2>How Actionability is Achieved / Operationalized</h2>

<ul>
<li><p><strong>Framework/Approach Name(s):</strong> Evidence-Based Precision Medicine  </p></li>
<li><p><strong>Methods/Levers:</strong> Big data integration, bioinformatics analysis, interoperability standards, meta-analyses across “N-of-one” and large-scale cohorts  </p></li>
<li><p><strong>Operational Steps / Workflow:</strong> Data collection (EHR, wearables, genomics, etc.) → Standardization → Interoperable storage → Bioinformatics mining → Clinical decision support → Feedback to patient/clinician  </p></li>
<li><p><strong>Data &amp; Measures:</strong> Omics, imaging, clinical measures, behavioral and lifestyle data, environmental exposure  </p></li>
<li><p><strong>Implementation Context:</strong> Multi-institutional, transnational data-sharing systems  </p></li>
</ul>

<blockquote>
  <p>“…collation and meta-analyses of big data from cross-institutional and transnational large-scale registers and cohorts…” (p. 6)  </p>
</blockquote>

<blockquote>
  <p>“…create sustainable federated, safe data commons or warehouses…” (p. 6)</p>
</blockquote>

<h2>Dimensions and Attributes of Actionability (Authors’ Perspective)</h2>

<ul>
<li><p><strong>CL (Clarity):</strong> Yes — data must be interpretable for clinicians and patients.  </p></li>
<li><p><strong>CR (Contextual Relevance):</strong> Yes — personalized care requires context-specific relevance.  </p></li>
<li><p><strong>FE (Feasibility):</strong> Yes — operational constraints considered in prevention focus.  </p></li>
<li><p><strong>TI (Timeliness):</strong> Partial — early detection emphasized, but not deeply operationalized.  </p></li>
<li><p><strong>EX (Explainability):</strong> Yes — clinical bioinformatics bridges data complexity and clinical understanding.  </p></li>
<li><p><strong>GA (Goal Alignment):</strong> Yes — alignment to prevention, wellness, and patient-centered care.  </p></li>
<li><p><strong>Other Dimensions Named by Authors:</strong> Interoperability, standardization, patient empowerment.</p></li>
</ul>

<h2>Theoretical or Conceptual Foundations</h2>

<ul>
<li><p>Systems medicine (P4: predictive, preventive, personalized, participatory)  </p></li>
<li><p>Holistic integration of biological and environmental determinants of health  </p></li>
<li><p>N-of-one to N-of-many cohort aggregation</p></li>
</ul>

<h2>Indicators or Metrics for Actionability</h2>

<ul>
<li><p>Early detection of symptoms  </p></li>
<li><p>Identification of pre-symptomatic individuals  </p></li>
<li><p>Delay or prevention of disease onset  </p></li>
<li><p>Integration and usability of diverse data streams in decision-making</p></li>
</ul>

<h2>Barriers and Enablers to Actionability</h2>

<ul>
<li><p><strong>Barriers:</strong> Heterogeneous EHR systems, lack of interoperability, semantic complexity, data silos, privacy concerns, high costs, lack of training.  </p></li>
<li><p><strong>Enablers:</strong> Federated safe data commons, standardized vocabularies/ontologies, citizen participation, clinical bioinformatics expertise, wearable/self-monitoring technologies.</p></li>
</ul>

<h2>Relation to Existing Literature</h2>

<p>Positions precision and evidence-based medicine as complementary paradigms; builds on P4 medicine, systems biology, and big data health informatics literature.</p>

<h2>Summary</h2>

<p>Beckmann and Lew (2016) argue for integrating the population-level rigor of evidence-based medicine with the personalized depth of precision medicine, creating an “evidence-based precision medicine” paradigm. Actionability here means transforming diverse big data into clinically useful, context-relevant, and feasible recommendations that align with patient goals. This requires standardization, interoperability, large-scale data sharing, and advanced clinical bioinformatics to bridge data complexity and clinical decision-making. Key enablers include patient empowerment, wearable technology, and multi-modal data integration; challenges include semantic heterogeneity, privacy, economic feasibility, and education. The ultimate aim is to shift the focus from reactive treatment to proactive prevention and wellness.</p>

<h2>Scores</h2>

<ul>
<li><p><strong>Overall Relevance Score:</strong> 85 — Strong conceptual framing of actionability in a healthcare big data context; explicit features and conditions for actionability are present.  </p></li>
<li><p><strong>Operationalization Score:</strong> 70 — Provides a clear conceptual workflow and enabling infrastructure, but lacks detailed operational metrics or tested models.</p></li>
</ul>

<h2>Supporting Quotes from the Paper</h2>

<ul>
<li><p>“Proper data mining and translation of the vast datasets into clinically actionable knowledge…” (p. 1)  </p></li>
<li><p>“The real challenge… will be to… transform these extensive heterogeneous data into scalable, medically actionable resources…” (p. 8)  </p></li>
<li><p>“…collation and meta-analyses of big data from cross-institutional and transnational large-scale registers and cohorts…” (p. 6)  </p></li>
<li><p>“Shifting emphasis of medicine more from therapy to prevention, and from disease to wellness” (Table 1, p. 5)</p></li>
</ul>

<h2>Actionability References to Other Papers</h2>

<ul>
<li><p>Auffray et al. (2009, 2015) on systems medicine  </p></li>
<li><p>Hood &amp; Price (2014) on prevention-focused precision medicine  </p></li>
<li><p>Schwaederle &amp; Kurzrock (2015) on actionability in oncology  </p></li>
<li><p>Collins (2015) on NIH precision medicine perspective</p></li>
</ul>
